Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Service & Software > Global Endocrine Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Endocrine Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Service & Software

Published: 2025-11-16

Pages: 157 Pages

Report ld: 5475732

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global Endocrine Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Endocrine Testing Service leading manufacturers including Hoffmann-La Roche Ltd., Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A., Immunodiagnostic Systems, Laboratory Corporation of America Holdings, etc., dominate supply; the top five capture approximately % of global revenue, with Hoffmann-La Roche Ltd. leading 2024 sales at US$ million.

Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Endocrine Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Report Metric
Details
Report Title
Global Endocrine Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Market Size Available for Years
2025-2031
Global Endocrine Testing Service Companies Covered
Hoffmann-La Roche Ltd.
Abbott Laboratories
Agilent Technologies
BioMerieux S.A.
Bio-Rad Laboratories, Inc.
Siemens Healthineers
Danaher Corporation
DiaSorin S.p.A.
Immunodiagnostic Systems
Laboratory Corporation of America Holdings
Fujirebio, Inc.
Thermo Fisher Scientific Inc.
Quest Diagnostics
Sysmex Corporation
MP Biomedicals
Ortho Clinical Diagnostics
Meridian Life Science, Inc.
Global Endocrine Testing Service Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Endocrine Testing Service Market, Segment by Type
Prolactin Testing
Progesterone Testing
Testosterone Testing
Global Endocrine Testing Service Market, Segment by Application
Hospitals
Clinics
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Defines the Endocrine Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
    1.1 Introduction to Endocrine Testing Service: Definition, Properties, and Key Attributes
    1.2 Market Segmentation by Type
        1.2.1 Global Endocrine Testing Service Market Size by Type, 2020 VS 2024 VS 2031
        1.2.2 Prolactin Testing
        1.2.3 Progesterone Testing
        1.2.4 Testosterone Testing
    1.3 Market Segmentation by Application
        1.3.1 Global Endocrine Testing Service Market Size by Application, 2020 VS 2024 VS 2031
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Executive Summary
    2.1 Global Endocrine Testing Service Revenue Estimates and Forecasts 2020-2031
    2.2 Global Endocrine Testing Service Revenue by Region
        2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
        2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
        2.2.3 Global Revenue Market Share by Region (2020-2031)
        2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players
    3.1 Global Endocrine Testing Service Player Revenue Rankings and Profitability
        3.1.1 Global Revenue (Value) by Players (2020-2025)
        3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
        3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
        3.1.4 Gross Margin by Top Player (2020 VS 2024)
    3.2 Global Endocrine Testing Service Companies Headquarters and Service Footprint
    3.3 Main Product Type Market Size by Players
        3.3.1 Prolactin Testing Market Size by Players
        3.3.2 Progesterone Testing Market Size by Players
        3.3.3 Testosterone Testing Market Size by Players
    3.4 Global Endocrine Testing Service Market Concentration and Dynamics
        3.4.1 Global Market Concentration (CR5 and HHI)
        3.4.2 Entrant/Exit Impact Analysis
        3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis
    4.1 Global Endocrine Testing Service Revenue Trends by Type
        4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
        4.1.2 Global Revenue Market Share by Type (2020-2031)
    4.2 Key Product Attributes and Differentiation
    4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
        4.3.1 High-Growth Niches and Adoption Drivers
        4.3.2 Profitability Hotspots and Cost Drivers
        4.3.3 Substitution Threats

5 Global Downstream Application Analysis
    5.1 Global Endocrine Testing Service Revenue by Application
        5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
        5.1.2 Revenue Market Share by Application (2020-2031)
        5.1.3 High-Growth Application Identification
        5.1.4 Emerging Application Case Studies
    5.2 Downstream Customer Analysis
        5.2.1 Top Customers by Region
        5.2.2 Top Customers by Application

6 North America
    6.1 North America Market Size (2020-2031)
    6.2 North America Key Players Revenue in 2024
    6.3 North America Endocrine Testing Service Market Size by Type (2020-2031)
    6.4 North America Endocrine Testing Service Market Size by Application (2020-2031)
    6.5 North America Growth Accelerators and Market Barriers
    6.6 North America Endocrine Testing Service Market Size by Country
        6.6.1 North America Revenue Trends by Country
        6.6.2 US
        6.6.3 Canada
        6.6.4 Mexico

7 Europe
    7.1 Europe Market Size (2020-2031)
    7.2 Europe Key Players Revenue in 2024
    7.3 Europe Endocrine Testing Service Market Size by Type (2020-2031)
    7.4 Europe Endocrine Testing Service Market Size by Application (2020-2031)
    7.5 Europe Growth Accelerators and Market Barriers
    7.6 Europe Endocrine Testing Service Market Size by Country
        7.6.1 Europe Revenue Trends by Country
        7.6.2 Germany
        7.6.3 France
        7.6.4 U.K.
        7.6.5 Italy
        7.6.6 Russia

8 Asia-Pacific
    8.1 Asia-Pacific Market Size (2020-2031)
    8.2 Asia-Pacific Key Players Revenue in 2024
    8.3 Asia-Pacific Endocrine Testing Service Market Size by Type (2020-2031)
    8.4 Asia-Pacific Endocrine Testing Service Market Size by Application (2020-2031)
    8.5 Asia-Pacific Growth Accelerators and Market Barriers
    8.6 Asia-Pacific Endocrine Testing Service Market Size by Region
        8.6.1 Asia-Pacific Revenue Trends by Region
    8.7 China
    8.8 Japan
    8.9 South Korea
    8.10 Australia
    8.11 India
    8.12 Southeast Asia
        8.12.1 Indonesia
        8.12.2 Vietnam
        8.12.3 Malaysia
        8.12.4 Philippines
        8.12.5 Singapore

9 Central and South America
    9.1 Central and South America Market Size (2020-2031)
    9.2 Central and South America Key Players Revenue in 2024
    9.3 Central and South America Endocrine Testing Service Market Size by Type (2020-2031)
    9.4 Central and South America Endocrine Testing Service Market Size by Application (2020-2031)
    9.5 Central and South America Investment Opportunities and Key Challenges
    9.6 Central and South America Endocrine Testing Service Market Size by Country
        9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
        9.6.2 Brazil
        9.6.3 Argentina

10 Middle East and Africa
    10.1 Middle East and Africa Market Size (2020-2031)
    10.2 Middle East and Africa Key Players Revenue in 2024
    10.3 Middle East and Africa Endocrine Testing Service Market Size by Type (2020-2031)
    10.4 Middle East and Africa Endocrine Testing Service Market Size by Application (2020-2031)
    10.5 Middle East and Africa Investment Opportunities and Key Challenges
    10.6 Middle East and Africa Endocrine Testing Service Market Size by Country
        10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
        10.6.2 GCC Countries
        10.6.3 Israel
        10.6.4 Egypt
        10.6.5 South Africa

11 Corporate Profile
11.1 Hoffmann-La Roche Ltd.
11.1.1 Hoffmann-La Roche Ltd. Corporation Information
11.1.2 Hoffmann-La Roche Ltd. Business Overview
11.1.3 Hoffmann-La Roche Ltd. Endocrine Testing Service Product Features and Attributes
11.1.4 Hoffmann-La Roche Ltd. Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Hoffmann-La Roche Ltd. Endocrine Testing Service Revenue by Product in 2024
11.1.6 Hoffmann-La Roche Ltd. Endocrine Testing Service Revenue by Application in 2024
11.1.7 Hoffmann-La Roche Ltd. Endocrine Testing Service Revenue by Geographic Area in 2024
11.1.8 Hoffmann-La Roche Ltd. Endocrine Testing Service SWOT Analysis
11.1.9 Hoffmann-La Roche Ltd. Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Endocrine Testing Service Product Features and Attributes
11.2.4 Abbott Laboratories Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Laboratories Endocrine Testing Service Revenue by Product in 2024
11.2.6 Abbott Laboratories Endocrine Testing Service Revenue by Application in 2024
11.2.7 Abbott Laboratories Endocrine Testing Service Revenue by Geographic Area in 2024
11.2.8 Abbott Laboratories Endocrine Testing Service SWOT Analysis
11.2.9 Abbott Laboratories Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Corporation Information
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Endocrine Testing Service Product Features and Attributes
11.3.4 Agilent Technologies Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Agilent Technologies Endocrine Testing Service Revenue by Product in 2024
11.3.6 Agilent Technologies Endocrine Testing Service Revenue by Application in 2024
11.3.7 Agilent Technologies Endocrine Testing Service Revenue by Geographic Area in 2024
11.3.8 Agilent Technologies Endocrine Testing Service SWOT Analysis
11.3.9 Agilent Technologies Recent Developments
11.4 BioMerieux S.A.
11.4.1 BioMerieux S.A. Corporation Information
11.4.2 BioMerieux S.A. Business Overview
11.4.3 BioMerieux S.A. Endocrine Testing Service Product Features and Attributes
11.4.4 BioMerieux S.A. Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 BioMerieux S.A. Endocrine Testing Service Revenue by Product in 2024
11.4.6 BioMerieux S.A. Endocrine Testing Service Revenue by Application in 2024
11.4.7 BioMerieux S.A. Endocrine Testing Service Revenue by Geographic Area in 2024
11.4.8 BioMerieux S.A. Endocrine Testing Service SWOT Analysis
11.4.9 BioMerieux S.A. Recent Developments
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Corporation Information
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Endocrine Testing Service Product Features and Attributes
11.5.4 Bio-Rad Laboratories, Inc. Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Bio-Rad Laboratories, Inc. Endocrine Testing Service Revenue by Product in 2024
11.5.6 Bio-Rad Laboratories, Inc. Endocrine Testing Service Revenue by Application in 2024
11.5.7 Bio-Rad Laboratories, Inc. Endocrine Testing Service Revenue by Geographic Area in 2024
11.5.8 Bio-Rad Laboratories, Inc. Endocrine Testing Service SWOT Analysis
11.5.9 Bio-Rad Laboratories, Inc. Recent Developments
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Corporation Information
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Endocrine Testing Service Product Features and Attributes
11.6.4 Siemens Healthineers Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 Siemens Healthineers Recent Developments
11.7 Danaher Corporation
11.7.1 Danaher Corporation Corporation Information
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Endocrine Testing Service Product Features and Attributes
11.7.4 Danaher Corporation Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Danaher Corporation Recent Developments
11.8 DiaSorin S.p.A.
11.8.1 DiaSorin S.p.A. Corporation Information
11.8.2 DiaSorin S.p.A. Business Overview
11.8.3 DiaSorin S.p.A. Endocrine Testing Service Product Features and Attributes
11.8.4 DiaSorin S.p.A. Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 DiaSorin S.p.A. Recent Developments
11.9 Immunodiagnostic Systems
11.9.1 Immunodiagnostic Systems Corporation Information
11.9.2 Immunodiagnostic Systems Business Overview
11.9.3 Immunodiagnostic Systems Endocrine Testing Service Product Features and Attributes
11.9.4 Immunodiagnostic Systems Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Immunodiagnostic Systems Recent Developments
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Corporation Information
11.10.2 Laboratory Corporation of America Holdings Business Overview
11.10.3 Laboratory Corporation of America Holdings Endocrine Testing Service Product Features and Attributes
11.10.4 Laboratory Corporation of America Holdings Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Fujirebio, Inc.
11.11.1 Fujirebio, Inc. Corporation Information
11.11.2 Fujirebio, Inc. Business Overview
11.11.3 Fujirebio, Inc. Endocrine Testing Service Product Features and Attributes
11.11.4 Fujirebio, Inc. Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 Fujirebio, Inc. Recent Developments
11.12 Thermo Fisher Scientific Inc.
11.12.1 Thermo Fisher Scientific Inc. Corporation Information
11.12.2 Thermo Fisher Scientific Inc. Business Overview
11.12.3 Thermo Fisher Scientific Inc. Endocrine Testing Service Product Features and Attributes
11.12.4 Thermo Fisher Scientific Inc. Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 Thermo Fisher Scientific Inc. Recent Developments
11.13 Quest Diagnostics
11.13.1 Quest Diagnostics Corporation Information
11.13.2 Quest Diagnostics Business Overview
11.13.3 Quest Diagnostics Endocrine Testing Service Product Features and Attributes
11.13.4 Quest Diagnostics Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.13.5 Quest Diagnostics Recent Developments
11.14 Sysmex Corporation
11.14.1 Sysmex Corporation Corporation Information
11.14.2 Sysmex Corporation Business Overview
11.14.3 Sysmex Corporation Endocrine Testing Service Product Features and Attributes
11.14.4 Sysmex Corporation Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.14.5 Sysmex Corporation Recent Developments
11.15 MP Biomedicals
11.15.1 MP Biomedicals Corporation Information
11.15.2 MP Biomedicals Business Overview
11.15.3 MP Biomedicals Endocrine Testing Service Product Features and Attributes
11.15.4 MP Biomedicals Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.15.5 MP Biomedicals Recent Developments
11.16 Ortho Clinical Diagnostics
11.16.1 Ortho Clinical Diagnostics Corporation Information
11.16.2 Ortho Clinical Diagnostics Business Overview
11.16.3 Ortho Clinical Diagnostics Endocrine Testing Service Product Features and Attributes
11.16.4 Ortho Clinical Diagnostics Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.16.5 Ortho Clinical Diagnostics Recent Developments
11.17 Meridian Life Science, Inc.
11.17.1 Meridian Life Science, Inc. Corporation Information
11.17.2 Meridian Life Science, Inc. Business Overview
11.17.3 Meridian Life Science, Inc. Endocrine Testing Service Product Features and Attributes
11.17.4 Meridian Life Science, Inc. Endocrine Testing Service Revenue and Gross Margin (2020-2025)
11.17.5 Meridian Life Science, Inc. Recent Developments

12 Endocrine Testing ServiceIndustry Chain Analysis
    12.1 Endocrine Testing Service Industry Chain
    12.2 Upstream Analysis
        12.2.1 Upstream Key Suppliers
    12.3 Middlestream Analysis
    12.4 Downstream Sales Model and Distribution Networks
        12.4.1 Sales Channels
        12.4.2 Distributors

13 Endocrine Testing Service Market Dynamics
    13.1 Industry Trends and Evolution
    13.2 Market Growth Drivers and Emerging Opportunities
    13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Endocrine Testing Service Study

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Endocrine Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Endocrine Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Endocrine Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Endocrine Testing Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Endocrine Testing Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Endocrine Testing Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Endocrine Testing Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Endocrine Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Testing Service as of 2024)
 Table 11. Global Endocrine Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Endocrine Testing Service Companies Headquarters
 Table 13. Global Endocrine Testing Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Endocrine Testing Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Endocrine Testing Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Endocrine Testing Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Endocrine Testing Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Endocrine Testing Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Endocrine Testing Service Growth Accelerators and Market Barriers
 Table 25. North America Endocrine Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Endocrine Testing Service Growth Accelerators and Market Barriers
 Table 27. Europe Endocrine Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Endocrine Testing Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Endocrine Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Endocrine Testing Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Endocrine Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Endocrine Testing Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Endocrine Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Hoffmann-La Roche Ltd. Corporation Information
 Table 35. Hoffmann-La Roche Ltd. Description and Major Businesses
 Table 36. Hoffmann-La Roche Ltd. Product Features and Attributes
 Table 37. Hoffmann-La Roche Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Hoffmann-La Roche Ltd. Revenue Proportion by Product in 2024
 Table 39. Hoffmann-La Roche Ltd. Revenue Proportion by Application in 2024
 Table 40. Hoffmann-La Roche Ltd. Revenue Proportion by Geographic Area in 2024
 Table 41. Hoffmann-La Roche Ltd. Endocrine Testing Service SWOT Analysis
 Table 42. Hoffmann-La Roche Ltd. Recent Developments
 Table 43. Abbott Laboratories Corporation Information
 Table 44. Abbott Laboratories Description and Major Businesses
 Table 45. Abbott Laboratories Product Features and Attributes
 Table 46. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Abbott Laboratories Revenue Proportion by Product in 2024
 Table 48. Abbott Laboratories Revenue Proportion by Application in 2024
 Table 49. Abbott Laboratories Revenue Proportion by Geographic Area in 2024
 Table 50. Abbott Laboratories Endocrine Testing Service SWOT Analysis
 Table 51. Abbott Laboratories Recent Developments
 Table 52. Agilent Technologies Corporation Information
 Table 53. Agilent Technologies Description and Major Businesses
 Table 54. Agilent Technologies Product Features and Attributes
 Table 55. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Agilent Technologies Revenue Proportion by Product in 2024
 Table 57. Agilent Technologies Revenue Proportion by Application in 2024
 Table 58. Agilent Technologies Revenue Proportion by Geographic Area in 2024
 Table 59. Agilent Technologies Endocrine Testing Service SWOT Analysis
 Table 60. Agilent Technologies Recent Developments
 Table 61. BioMerieux S.A. Corporation Information
 Table 62. BioMerieux S.A. Description and Major Businesses
 Table 63. BioMerieux S.A. Product Features and Attributes
 Table 64. BioMerieux S.A. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. BioMerieux S.A. Revenue Proportion by Product in 2024
 Table 66. BioMerieux S.A. Revenue Proportion by Application in 2024
 Table 67. BioMerieux S.A. Revenue Proportion by Geographic Area in 2024
 Table 68. BioMerieux S.A. Endocrine Testing Service SWOT Analysis
 Table 69. BioMerieux S.A. Recent Developments
 Table 70. Bio-Rad Laboratories, Inc. Corporation Information
 Table 71. Bio-Rad Laboratories, Inc. Description and Major Businesses
 Table 72. Bio-Rad Laboratories, Inc. Product Features and Attributes
 Table 73. Bio-Rad Laboratories, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Bio-Rad Laboratories, Inc. Revenue Proportion by Product in 2024
 Table 75. Bio-Rad Laboratories, Inc. Revenue Proportion by Application in 2024
 Table 76. Bio-Rad Laboratories, Inc. Revenue Proportion by Geographic Area in 2024
 Table 77. Bio-Rad Laboratories, Inc. Endocrine Testing Service SWOT Analysis
 Table 78. Bio-Rad Laboratories, Inc. Recent Developments
 Table 79. Siemens Healthineers Corporation Information
 Table 80. Siemens Healthineers Description and Major Businesses
 Table 81. Siemens Healthineers Product Features and Attributes
 Table 82. Siemens Healthineers Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Siemens Healthineers Recent Developments
 Table 84. Danaher Corporation Corporation Information
 Table 85. Danaher Corporation Description and Major Businesses
 Table 86. Danaher Corporation Product Features and Attributes
 Table 87. Danaher Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Danaher Corporation Recent Developments
 Table 89. DiaSorin S.p.A. Corporation Information
 Table 90. DiaSorin S.p.A. Description and Major Businesses
 Table 91. DiaSorin S.p.A. Product Features and Attributes
 Table 92. DiaSorin S.p.A. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. DiaSorin S.p.A. Recent Developments
 Table 94. Immunodiagnostic Systems Corporation Information
 Table 95. Immunodiagnostic Systems Description and Major Businesses
 Table 96. Immunodiagnostic Systems Product Features and Attributes
 Table 97. Immunodiagnostic Systems Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Immunodiagnostic Systems Recent Developments
 Table 99. Laboratory Corporation of America Holdings Corporation Information
 Table 100. Laboratory Corporation of America Holdings Description and Major Businesses
 Table 101. Laboratory Corporation of America Holdings Product Features and Attributes
 Table 102. Laboratory Corporation of America Holdings Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Laboratory Corporation of America Holdings Recent Developments
 Table 104. Fujirebio, Inc. Corporation Information
 Table 105. Fujirebio, Inc. Description and Major Businesses
 Table 106. Fujirebio, Inc. Product Features and Attributes
 Table 107. Fujirebio, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Fujirebio, Inc. Recent Developments
 Table 109. Thermo Fisher Scientific Inc. Corporation Information
 Table 110. Thermo Fisher Scientific Inc. Description and Major Businesses
 Table 111. Thermo Fisher Scientific Inc. Product Features and Attributes
 Table 112. Thermo Fisher Scientific Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Thermo Fisher Scientific Inc. Recent Developments
 Table 114. Quest Diagnostics Corporation Information
 Table 115. Quest Diagnostics Description and Major Businesses
 Table 116. Quest Diagnostics Product Features and Attributes
 Table 117. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Quest Diagnostics Recent Developments
 Table 119. Sysmex Corporation Corporation Information
 Table 120. Sysmex Corporation Description and Major Businesses
 Table 121. Sysmex Corporation Product Features and Attributes
 Table 122. Sysmex Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Sysmex Corporation Recent Developments
 Table 124. MP Biomedicals Corporation Information
 Table 125. MP Biomedicals Description and Major Businesses
 Table 126. MP Biomedicals Product Features and Attributes
 Table 127. MP Biomedicals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. MP Biomedicals Recent Developments
 Table 129. Ortho Clinical Diagnostics Corporation Information
 Table 130. Ortho Clinical Diagnostics Description and Major Businesses
 Table 131. Ortho Clinical Diagnostics Product Features and Attributes
 Table 132. Ortho Clinical Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Ortho Clinical Diagnostics Recent Developments
 Table 134. Meridian Life Science, Inc. Corporation Information
 Table 135. Meridian Life Science, Inc. Description and Major Businesses
 Table 136. Meridian Life Science, Inc. Product Features and Attributes
 Table 137. Meridian Life Science, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Meridian Life Science, Inc. Recent Developments
 Table 139. Raw Materials Key Suppliers
 Table 140. Distributors List
 Table 141. Market Trends and Market Evolution
 Table 142. Market Drivers and Opportunities
 Table 143. Market Challenges, Risks, and Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources


List of Figures
 Figure 1. Endocrine Testing Service Product Picture
 Figure 2. Global Endocrine Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Prolactin Testing Product Picture
 Figure 4. Progesterone Testing Product Picture
 Figure 5. Testosterone Testing Product Picture
 Figure 6. Global Endocrine Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospitals
 Figure 8. Clinics
 Figure 9. Endocrine Testing Service Report Years Considered
 Figure 10. Global Endocrine Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Endocrine Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Endocrine Testing Service Revenue Market Share by Region (2020-2031)
 Figure 14. Global Endocrine Testing Service Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Prolactin Testing Revenue Market Share by Player in 2024
 Figure 17. Progesterone Testing Revenue Market Share by Player in 2024
 Figure 18. Testosterone Testing Revenue Market Share by Player in 2024
 Figure 19. Global Endocrine Testing Service Revenue Market Share by Type (2020-2031)
 Figure 20. Global Endocrine Testing Service Revenue Market Share by Application (2020-2031)
 Figure 21. North America Endocrine Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Endocrine Testing Service Revenue (US$ Million) in 2024
 Figure 23. North America Endocrine Testing Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Endocrine Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Endocrine Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Endocrine Testing Service Revenue (US$ Million) in 2024
 Figure 30. Europe Endocrine Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Endocrine Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 33. France Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Endocrine Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Endocrine Testing Service Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Endocrine Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Endocrine Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 45. India Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Endocrine Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Endocrine Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Endocrine Testing Service Revenue (US$ Million) in 2024
 Figure 53. Central and South America Endocrine Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Endocrine Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Endocrine Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Endocrine Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Endocrine Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Endocrine Testing Service Revenue (US$ Million) in 2024
 Figure 59. South America Endocrine Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Endocrine Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Endocrine Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Endocrine Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Endocrine Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Endocrine Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 65. Endocrine Testing Service Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed